World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
45640
World Ranking
6207
National Ranking
3308

William S. Dalton publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where William S. Dalton sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 420 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

William S. Dalton D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where William S. Dalton sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2018 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2013 - Fellow, National Academy of Inventors

Overview

William S. Dalton is affiliated with the University of South Florida in the United States. Their research predominantly spans the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Within these, they have focused on subfields including Molecular Biology, Cancer Research, Oncology, Immunology, and Hematology.

The primary topics of Dalton's research include:

  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Protein Degradation and Inhibitors
  • Multiple Myeloma Research and Treatments
  • Immune cells in cancer
  • Histone Deacetylase Inhibitors Research
  • Vaccines and immunoinformatics approaches

Dalton has contributed to several recent papers, reflecting ongoing involvement in cancer and immunology research. Notable publications include:

  • "Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease", 2020, Leukemia
  • "Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma", 2021, JCI Insight
  • "Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages", 2024, Immunity
  • "Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes.", 2023, Journal of Clinical Oncology
  • "Abstract IA27: An innovative approach to improve clinical trials using adaptive in silico design", 2020, Cancer Epidemiology Biomarkers & Prevention

They have frequently published in venues such as:

  • Regular and Young Investigator Award Abstracts
  • Leukemia
  • Immunity
  • JCI Insight
  • Journal of Clinical Oncology

Dalton's frequent collaborators include:

  • Ahmad A. Tarhini
  • Michelle L. Churchman
  • Aakrosh Ratan
  • Martin D. McCarter
  • John D. Carpten

Recognition of Dalton's contributions includes being named a Fellow of the American Association for the Advancement of Science (AAAS) in 2018 and as a Fellow of the National Academy of Inventors in 2013.

Best Publications

  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

    Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin

  • Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

    Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie

  • Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

    Robyn Catlett-Falcone;Terry H Landowski;Marc M Oshiro;James Turkson

  • Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

    R H Collins;O Shpilberg;W R Drobyski;D L Porter

  • Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.

    Tianhong Wang;Guilian Niu;Marcin Kortylewski;Lyudmila Burdelya

  • Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines

    Jason S. Damiano;Anne E. Cress;Lori A. Hazlehurst;Lori A. Hazlehurst;Alexander A. Shtil;Alexander A. Shtil

  • Environment-mediated drug resistance: a major contributor to minimal residual disease

    Mark B. Meads;Robert A. Gatenby;William S. Dalton

  • MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

    William Kong;Hua Yang;Lili He;Jian Jun Zhao

  • Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance.

    R.J. Scheper;H.J. Broxterman;G.L. Scheffer;P. Kaaijk

  • Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

    W. S. Dalton;T. M. Grogan;P. S. Meltzer;R. J. Scheper

  • Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.

    Paul Gerard Richardson;Pieter Sonneveld;Michael Schuster;David Irwin

  • A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

    Paul G. Richardson;Emily Blood;Constantine S. Mitsiades;Sundar Jagannath

  • The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.

    Mark B. Meads;Lori A. Hazlehurst;William S. Dalton

  • Methods to Detect P-Glycoprotein-associated Multidrug Resistance in Patients' Tumors: Consensus Recommendations

    William T. Beck;Thomas M. Grogan;Cheryl L. Willman;Carlos Cordon-Cardo

  • Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.

    Douglas D. Ross;Weidong Yang;Lynne V. Abruzzo;William S. Dalton

  • P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

    Thomas P. Miller;Thomas M. Grogan;William S. Dalton;Catherine M. Spier

  • Gene Therapy with Dominant-negative Stat3 Suppresses Growth of the Murine Melanoma B16 Tumor in Vivo

    Guilian Niu;Richard Heller;Robyn Catlett-Falcone;Domenico Coppola

  • Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR).

    L A Hazlehurst;J S Damiano;I Buyuksal;W J Pledger

  • P-glycoprotein expression and function in circulating blood cells from normal volunteers

    Walter T. Klimecki;Bernard W. Futscher;Thomas M. Grogan;William S. Dalton

  • A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

    Jacob G Scott;Anders Berglund;Michael J Schell;Ivaylo Mihaylov

Frequent Co-Authors

Sydney E. Salmon
Sydney E. Salmon University of Arizona
Thomas M. Grogan
Thomas M. Grogan Roche (Switzerland)
Richard Jove
Richard Jove Nova Southeastern University
Claudio Anasetti
Claudio Anasetti Fred Hutchinson Cancer Research Center
John M. Koomen
John M. Koomen University of South Florida
Hua Yu
Hua Yu City Of Hope National Medical Center
Alan F. List
Alan F. List Precision BioSciences
Bernard W. Futscher
Bernard W. Futscher University of Arizona
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Paul G. Richardson
Paul G. Richardson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up diverse educational and career options, including flexible online programs. Many registered nurses are seeking to advance their qualifications and earning potential by enrolling in rn to bsn cheapest programs. These affordable online pathways help RNs obtain a Bachelor of Science in Nursing while balancing work and personal commitments.

For those with a non-nursing background interested in healthcare leadership roles, direct entry online msn programs offer a fast-tracked route to a Master of Science in Nursing. These innovative programs are designed for career changers who want to enter advanced nursing fields quickly.

Students concerned about admissions criteria may find it helpful to research whats the easiest nursing program to get into?. Certain schools offer streamlined entry requirements, making a nursing education more accessible to a broader range of applicants.

Besides direct patient care, healthcare offers in-demand administrative careers. If you’re interested in the business side of medicine, consider studying online medical billing and coding with financial aid. These programs can provide stepping stones into the healthcare industry for those seeking flexibility and financial support.

Best Scientists Citing William S. Dalton

Trending Scientists

Recently Published Articles